Ultragenyx Pharmaceutical | RARE - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2026 -1.16 -1.04 -1.81 Nov/03
FY2026Q2 Jun/2026 -0.90 -1.23 -1.17 Aug/04
FY2026Q1 Mar/2026 -1.84 -1.43 -1.57 May/05
FY2025Q4 Dec/2025 -1.29 -1.17 -1.39 Feb/12
FY2025Q3 Sep/2025 -1.81 -1.23 -1.40 Nov/04




Eps Alterar Data
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
Agios Pharmaceuticals USD -1.09 0.6 2026-09
Alnylam Pharmaceuticals USD 16.26 14.42 2026-09
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
BioMarin Pharmaceutical USD 0.23 0.97 2026-09
Immunic USD -0.1 0.03 2025-12
Insmed USD -0.46 0.4 2026-09
Ionis Pharmaceuticals USD 0.66 1.35 2026-09
Karyopharm Therapeutics USD -1.02 1.2 2026-03
Kyowa Hakko Kirin JPY 40.22 4.73 2026-09
MacroGenics USD 0.31 0.89 2026-06
Moderna USD 0.38 2.35 2026-09
Neurocrine Biosciences USD 3.29 0.44 2026-09
PTC Therapeutics USD -0.62 1.54 2026-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 20.07 5.78 2026-09
Sarepta Therapeutics USD 0.13 0.51 2026-09
Ultragenyx Pharmaceutical USD -1.16 0.26 2026-09
Vertex Pharmaceuticals USD 4.76 0.03 2026-09